... “With just a few tablespoons of blood, we can now rapidly generate human monoclonal antibodies that potentially could be used for diagnosis and treatment of newly emerging strains of influenza,” says ...
... director of the cancer center at GUMC and an internationally recognized expert in development and use of monoclonal antibodies. "Treatment modifications might be able to prolong, amplify, and shape ...
New research suggests that monoclonal antibody therapy of cancer can be improved to be much more powerful than it is today.
... specific to cancer cells, killing them with few or no side effects. For several types of cancer, monoclonal antibodies have already offered this advantage to patients. For other cancer ...
... in the field of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. "The use of monoclonal antibodies is rising for a number of gastroenterological disorders, such as inflammatory ...
... future pandemics. Researchers report in Nature today that they have perfected a way to manufacture monoclonal antibodies capable of destroying diseases such the avian flu, which have the ability to ...
A chemist has discovered a new marker together with three associated monoclonal antibodies which are promising candidates for cancer therapy. Up to now, monoclonal antibodies have only aided the ...
... Genentech's Jennie Lill. "DNA sequencing is routinely used in the initial characterization of monoclonal antibodies, but subsequent mutations and other changes mean that further protein level analysis ...
Bioinformatics researchers have developed a new, quicker way to sequence monoclonal antibodies -- a process that is many times faster than the sequencing technology typically used by academic and ...
... , Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and serious virus infections, today reported that two preclinical studies ...
... proven so elusive."
Y-shaped antibodies are best at neutralizing viruses--i.e., ... looked at the neutralization capabilities of two different monoclonal antibodies isolated from HIV-infected individuals ...
... Hepatitis C virus (HCV). The new antibody effectively neutralized the virus in culture, and then ... infect the new liver. Then, because monoclonal antibodies are highly specific and typically have little ...
... is the only genetically engineered animal commercially available for the generation of human monoclonal antibodies, and many targets are licensed already. The expense and limitations of the mouse ...
... the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody they developed that can neutralize the Hepatitis C virus (HCV). The first volunteer received ...
... small synthetic HIV-1 peptides encapsulated in liposomes containing lipid A as an adjuvant.
The monoclonal antibodies, produced after immunizing mice, have binding characteristics that look similar ...
